Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, Trauner M, Jones DE, Floreani A, Hohenester S, Luketic V, Shiffman M, van Erpecum KJ, Vargas V, Vincent C, Hirschfield GM, Shah H, Hansen B, Lindor KD, Marschall HU, Kowdley KV, Hooshmand-Rad R, Marmon T, Sheeron S, Pencek R, MacConell L, Pruzanski M, Shapiro D; POISE Study Group.

N Engl J Med. 2016 Aug 18;375(7):631-43. doi: 10.1056/NEJMoa1509840.

2.

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.

Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium, Gershwin ME, Anderson CA, Lazaridis KN, Invernizzi P, Seldin MF, Sandford RN, Amos CI, Siminovitch KA.

Nat Commun. 2015 Sep 22;6:8019. doi: 10.1038/ncomms9019.

3.

A randomized trial of a hepatitis care coordination model in methadone maintenance treatment.

Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC Jr, Sorensen JL, Des Jarlais DC, Perlman DC.

Am J Public Health. 2013 Oct;103(10):e81-8. doi: 10.2105/AJPH.2013.301458. Epub 2013 Aug 15.

4.

The impact of race on organ donation authorization discussed in the context of liver transplantation.

Bodenheimer HC Jr, Okun JM, Tajik W, Obadia J, Icitovic N, Friedmann P, Marquez E, Goldstein MJ.

Trans Am Clin Climatol Assoc. 2012;123:64-77; discussion 77-8.

5.

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, Kosoy R, Ransom M, Sun Y, Bianchi I, Schlicht EM, Lleo A, Coltescu C, Bernuzzi F, Podda M, Lammert C, Shigeta R, Chan LL, Balschun T, Marconi M, Cusi D, Heathcote EJ, Mason AL, Myers RP, Milkiewicz P, Odin JA, Luketic VA, Bacon BR, Bodenheimer HC Jr, Liakina V, Vincent C, Levy C, Franke A, Gregersen PK, Bossa F, Gershwin ME, deAndrade M, Amos CI; Italian PBC Genetics Study Group, Lazaridis KN, Seldin MF, Siminovitch KA.

Hum Mol Genet. 2012 Dec 1;21(23):5209-21. doi: 10.1093/hmg/dds359. Epub 2012 Aug 29.

6.

Keratin 19 demonstration of canal of Hering loss in primary biliary cirrhosis: "minimal change PBC"?

Khan FM, Komarla AR, Mendoza PG, Bodenheimer HC Jr, Theise ND.

Hepatology. 2013 Feb;57(2):700-7. doi: 10.1002/hep.26020.

PMID:
22911653
7.

Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.

Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, Doo E, Meyers CM, Reddy KR; Silymarin in NASH and C Hepatitis (SyNCH) Study Group.

JAMA. 2012 Jul 18;308(3):274-82. doi: 10.1001/jama.2012.8265.

8.

Retreatment of patients nonresponsive to pegylated interferon and ribavirin with daily high-dose consensus interferon.

Meyer DF, Tobias H, Min AD, Rajendra A, Zic I, Brettholz E, Clain DJ, Klion F, Bernstein D, Bodenheimer HC.

Hepat Res Treat. 2010;2010:537827. doi: 10.1155/2010/537827. Epub 2010 Oct 10.

9.

Hepatic lipogranulomas in patients with chronic liver disease: association with hepatitis C and fatty liver disease.

Zhu H, Bodenheimer HC Jr, Clain DJ, Min AD, Theise ND.

World J Gastroenterol. 2010 Oct 28;16(40):5065-9.

10.

Trends in the indication and method of liver biopsy for hepatitis B and C.

Lipp MJ, D'Souza LS, Clain DJ, Bodenheimer HC Jr, Min AD.

Dig Dis Sci. 2010 Oct;55(10):2971-6. doi: 10.1007/s10620-010-1337-8. Epub 2010 Jul 15.

PMID:
20632096
11.

Commentary.

Bodenheimer HC.

Clin Chem. 2009 Aug;55(8):1576-7. doi: 10.1373/clinchem.2009.129601. No abstract available.

12.

Remission of aseptic inflammatory ascites after nephrectomy of a failed allograft.

Wan DW, Serur D, Bodenheimer HC Jr, Goldstein MJ, Sigal SH.

Am J Kidney Dis. 2008 Sep;52(3):626. doi: 10.1053/j.ajkd.2008.05.034. No abstract available.

PMID:
18725018
13.

Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.

Bonkovsky HL, Tice AD, Yapp RG, Bodenheimer HC Jr, Monto A, Rossi SJ, Sulkowski MS.

Am J Gastroenterol. 2008 Nov;103(11):2757-65. doi: 10.1111/j.1572-0241.2008.02065.x. Epub 2008 Aug 5.

PMID:
18684176
14.

Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.

Lin A, Kadam JS, Bodenheimer HC, Leonard J, Joyce MA, Lake-Bakaar G.

J Med Virol. 2008 Aug;80(8):1350-3. doi: 10.1002/jmv.21109.

PMID:
18551608
15.

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.

Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC; Public Policy Committee of the American Association for the Study of Liver Disease.

Hepatology. 2008 Apr;47(4):1363-70. doi: 10.1002/hep.22109. No abstract available.

PMID:
18366115
16.

Serrated adenoma is a risk factor for subsequent adenomatous polyps.

Glazer E, Golla V, Forman R, Zhu H, Levi G, Bodenheimer HC Jr.

Dig Dis Sci. 2008 Aug;53(8):2204-7. doi: 10.1007/s10620-007-0143-4. Epub 2008 Mar 5.

PMID:
18320324
17.

Remission of aseptic inflammatory ascites after nephrectomy of a failed allograft.

Wan DW, Serur D, Bodenheimer HC Jr, Goldstein MJ, Sigal SH.

Am J Kidney Dis. 2007 Oct;50(4):645-8.

PMID:
17900465
18.

Chronic hepatitis C virus and celiac disease, is there an association?

Hernandez L, Johnson TC, Naiyer AJ, Kryszak D, Ciaccio EJ, Min A, Bodenheimer HC Jr, Brown RS Jr, Fasano A, Green PH.

Dig Dis Sci. 2008 Jan;53(1):256-61. Epub 2007 Jun 5.

PMID:
17549632
19.

Treatment rates in patients with chronic hepatitis C after liver biopsy.

Narasimhan G, Sargios TN, Kalakuntla R, Homel P, Clain DJ, Theise ND, Bodenheimer HC Jr, Min AD.

J Viral Hepat. 2006 Nov;13(11):783-6.

PMID:
17052279
20.

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment.

Gopal K, Johnson TC, Gopal S, Walfish A, Bang CT, Suwandhi P, Pena-Sahdala HN, Clain DJ, Bodenheimer HC Jr, Min AD.

Hepatology. 2006 Aug;44(2):335-40.

PMID:
16871569

Supplemental Content

Loading ...
Support Center